Flow Cytometry Market in Asia Pacific is expected to grow at the fastest rate | Says FMI Analyst

 The Global Flow Cytometry Market is expected to enjoy a lucrative growth opportunity with an expanded CAGR of 7.4% from 2022 to 2032. The global market is anticipated to reach a valuation of US$ 5.6 Billion by the end of the year 2022 and reach an estimation of nearly US$ 11.4 Billion by the year 2032. According to the reports conducted by Future Market Insights on the flow cytometry market, the reagents, consumables & accessories are leading the market by product, with a share of about 44.3% in the year 2021, within the global market.

For more information @ https://www.futuremarketinsights.com/reports/flow-cytometry-market

Global flow cytometry is expected to become even more vital in medicine because of high-throughput quantitative analysis, developments in vivo flow cytometry, and assessments of minimal residual diseases.

Flow Cytometry Market


The demand for flow cytometry is anticipated to surge strong, offsetting any industry margin compressions. The flow cytometry techniques offer impressive diagnostic opportunities in the majority of oncologic and hematologic diseases by providing multiple molecular and cellular knowledge within an individual cell. The flow cytometry market comprises some specific applications of the benchtop, specifically in hematology and oncology areas, in addition to general limitations that have proved lucrative for the said market.  

The flow cytometry market share is expected to benefit from surging healthcare spending and increased public awareness. Cell sorting, immunophenotyping, intracellular calcium flux, and cell proliferation assays are a few of the numerous applications of the FASCaliber flow cytometer. This technique accounts for several benefits such as its user-friendliness, which are further projected to boost its demand during the forecasted years. For all the cytometry market participants, this method is increasingly used in clinical studies and research which has opened up a variety of new growth prospects all over the world.

Key Takeaways

  • A rising number of immunoassay techniques are rapidly being developed including the Accuri flow cytometer attributed to the recombinant antibody technology. Recombinant antibodies are extensively being used during the development of more sophisticated panels that come with affordable flow cytometer prices.
  • By combining the high specificity and affinity of monoclonal antibodies with recombinant technology, monoclonal antibodies incorporate a stronger ability to detect subtle antigenic alterations and small targets comprising epitope variants, post-translational modifications, and conformational changes.
  • Furthermore, nowadays it has become very common to change the flow cytometry region in order to avoid clashes with several other antibodies within a flow cytometry panel. By decreasing the high background which commonly takes place when antibodies bind to Fc receptors, recombinant antibodies have reduced the flow cytometry cost. As a result, varieties of market opportunities are now being established by the introduction of recombinant DNA technology for antibody production in flow cytometry.
  • The development of monoclonal antibodies, fluorescence, and laser technology has managed to diversify by adding new options for developing the best flow cytometers to investigate intracellular compartments for the determination of cellular functionality. In addition to that, the expansion of business over digital distribution channels has proven to be groundbreaking development for several small flow cytometer manufacturers with a limited and dispersed customer base.

Key Players Profiled in the Flow Cytometry Market Report

  • Beckman Coulter, Inc. (Danaher)
  • Becton Dickinson & Co.
  • Life Technologies Corporation (Thermo Fisher Scientific Inc.)
  • Miltenyi Biotech
  • Luminex Corp.
  • Merck KGaA
  • bioMérieux SA
  • Agilent Technologies
  • Bio-Rad Laboratories
  • Apogee Flow Systems Ltd.
  • Sysmex Partec
  • Sony Biotechnology
  • Cytek® Biosciences
  • Sartorius AG
  • Hamamatsu Photonics K.K
  • FURUKAWA ELECTRIC CO., LTD.
  • Accellix.
  • Shenzhen Mindray Bio-Medical Electronics Co., Ltd

Full Information Source @ https://www.futuremarketinsights.com/reports/flow-cytometry-market

Key Segments

By Product Type:

  • Flow Cytometer System
    • Tradition Flow Cytometer
      • Cell Sorters
      • Imaging Flow Cytometers
    • Acoustic Focusing Cytometers
    • Next Generation Flow Cytometers
    • Reagents, Consumables & Accessories
    • Software
    • Services

By Application:

  • Immunophenotyping
  • Cell Sorting
  • Cell Cycle Analysis
    • Apoptosis
    • Cell Proliferation Assays
    • Intracellular Calcium Flux
  • Detection & Sorting of Exosomes
  • Others

By Usage:

  • Research Use
  • Clinical Diagnostics

By End User:

  • Hospitals
  • Diagnostic Laboratories
  • Academic and Research Institute
  • Biopharmaceutical Companies

Comments

Post a Comment

Popular posts from this blog

Pet Diabetes Care Devices Market Report | Size, Growth, Demand, Scope and Forecast to 2032

  The global  Pet Diabetes Care Devices Market  is expected to grow at a  6.5%  CAGR, reaching  US$ 4 billion  by 2032, up from  US$ 2 billion  in 2021. “The number of pets with diabetes, the number of adopted pets, and the number of overweight pets are all driving the market forward.” Get Full Access @ https://www.futuremarketinsights.com/reports/pet-diabetes-care-devices-market The domestication of animals is leading to a lack of insulin production in them. The limited flow of glucose to the cell can be termed diabetes. This chronic disease is a major concern for pet owners and needs to be taken care of. This concern leads to the expansion of the pet diabetes care devices market. Devices like the alphatrak blood glucose meter are in use as they help the pet owners monitor the pet’s health. The increased number of people adopting pets and then domesticating them around in their households, treating and caring for them as f...
Read more

Human Immunodeficiency Virus Type 1 (HIV 1) Market Opportunity, Competitive Analysis, Future Prospects to 2033

Image
  The global Human Immunodeficiency Virus Type 1 (HIV 1) Market is predicted to exceed a remarkable valuation of US$ 34.83 Billion in 2023, with a compound annual rate of growth (CAGR) of 6% estimated from 2023 to 2033. The Institute for Health Metrics and Evaluation attributes the industry's growth to the soaring incidence rate of HIV-1 infection, which, unlike the deaths caused from this viral illness, has not updated substantially over time. Get Full Access @ https://www.futuremarketinsights.com/reports/human-immunodeficiency-virus-type-1-hiv1-market It affected approximately 37 million people worldwide. Furthermore, antiretroviral therapeutic interventions for disease management are only available to half of this population. HIV-1 is the more common of the two types of human immunodeficiency virus, accounting for approximately 96% of all infections globally. The prevalence of HIV is rising at an alarming rate. The World Health Organization (WHO) estimates that 33.0 million...
Read more

Clostridium Diagnostics Market in US is anticipated to secure a market value worth US$ 2.7 Billion by 2032 | FMI

Image
  The global Clostridium Diagnostics Market is expected to grow at a CAGR of 12.2% during the forecast period, from US$ 2.5 billion in 2022 to US$ 7.8 billion by 2032. The market grew at a CAGR of 13.6% between 2015 and 2021. The rising prevalence of clostridium-related diseases, as well as increased campaigns to educate people about the condition, are driving the market growth. To learn more about this report @ https://www.futuremarketinsights.com/reports/clostridium-diagnostics-market here has been an increased focus of players in the market to offer vaccines, which can augment the market size in the forecast period. For instance, in March 2022, Japan launched a new center, with a budget of US$ 1.6 Billion, to support vaccine and drug projects as a part of a larger scheme to tackle infectious diseases. SCARDA will be in charge of establishing a flagship R&D site for innovative collaborations and controlling funds for R&D projects. Awareness camp...
Read more